Oxford Nanopore Technologies plc (LON:ONT – Get Free Report)’s share price was down 10.2% during trading on Monday . The stock traded as low as GBX 127 ($1.60) and last traded at GBX 128.50 ($1.62). Approximately 3,354,197 shares changed hands during mid-day trading, an increase of 54% from the average daily volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.80).
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on ONT shares. JPMorgan Chase & Co. restated an “overweight” rating on shares of Oxford Nanopore Technologies in a report on Friday, December 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 190 ($2.39) target price on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 282 ($3.54) price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, September 3rd. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Oxford Nanopore Technologies currently has an average rating of “Buy” and a consensus target price of GBX 235.50 ($2.96).
Check Out Our Latest Stock Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Stock Down 10.2 %
Insider Activity at Oxford Nanopore Technologies
In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of Oxford Nanopore Technologies stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total transaction of £2,830,870.82 ($3,558,158.40). In the last quarter, insiders acquired 310 shares of company stock valued at $45,010. Insiders own 32.62% of the company’s stock.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Recommended Stories
- Five stocks we like better than Oxford Nanopore Technologies
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- What Makes a Stock a Good Dividend Stock?
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.